Gurská Soňa Ph.D.
About me
I am working in the high throughput screening facility with focus on the testing of new chemical compounds, the implementation and validation of new biochemical and cell based assays into HTS. I am interested in identifying the active substances as potential drugs. I am experienced in liquid handling and robotic automation. Previously I was working in a field of mutagenesis and carcinogenesis at Cancer Reasearch Institute in Bratislava.
Journals
Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana.
Parasitology International.
2022,
91,
102647,
ISSN: 1383-5769,
PMID: 35985636,
Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence.
Neurosurgery.
2022,
91(2),
360-369,
ISSN: 0148-396X,
PMID: 35551164,
Amino-BODIPY as the ratiometric fluorescent sensor for monitoring drug release or "power supply" selector for molecular electronics.
RSC Advances.
2019,
9(43),
25075-25083,
ISSN: 2046-2069,
PMID: 35528670,
Open positions
| Project: | Drug repurposing for treatment and prevention of diseases |
|---|---|
| Supervisors: | Hajdúch Marián M.D., Ph.D., Gurská Soňa Ph.D. |
| Available: | 2 |
| Intended for: | Doctoral training |